# Milpharm Limited

A supplier with 13 awards on OpenContracts.

- PPON: PCYZ-5538-QLGR
- Address: Uxbridge, UB11
- Size: Large

## Awards

| Procurement | Buyer | Value | Date |
|---|---|---:|---|
| NHS National Generic Pharmaceuticals - Wave 16a (framework) | NHS England | £15,529,352 | 27 Aug 2026 |
| NHS National Generic Pharmaceuticals - Wave 16a (framework) | NHS England | £393,331,872 | 27 Aug 2026 |
| NHS National Generic Pharmaceuticals - Wave 16a (framework) | NHS England | £21,026,178 | 27 Aug 2026 |
| NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE  - 1 September 2026 (framework) | NHS England | £665,389,588 | 6 Jul 2026 |
| NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE  - 1 September 2026 (framework) | NHS England | £665,389,588 | 15 Jun 2026 |
| NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 (framework) | NHS England | £813,863,584 | 1 Jun 2026 |
| NHS National Generics Pharmaceuticals - Supply Chain Resilience (framework) | NHS England | £4,213,176 | 1 May 2026 |
| NHS National Generics Pharmaceuticals - Supply Chain Resilience (framework) | NHS England | £35,010,320 | 1 May 2026 |
| NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide (framework) | NHS England | £19,595,208 | 24 Mar 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c (framework) | NHS England | £403,702,000 | 13 Jan 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c (framework) | NHS England | £37,160,000 | 13 Jan 2026 |
| NHS National Framework for Generics Housekeeping (framework) | NHS England | £17,843,324 | 10 Nov 2025 |
| NHS National Framework for Generics Housekeeping (framework) | NHS England | £21,562,716 | 10 Nov 2025 |

---
Page: https://opencontracts.uk/supplier/milpharm-ltd
Contains public sector information licensed under the Open Government Licence v3.0. Source: Find a Tender and Contracts Finder, Cabinet Office.

